Amarin's Vascepa Momentum Builds Ahead Of Next Week's FDA AdComm

Sales going up
Vascepa sales were fueled by prescription growth
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapeutic Category